Predictive Oncology EPS - Earnings per Share 2010-2023 | POAI
Predictive Oncology eps - earnings per share from 2010 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Predictive Oncology Annual EPS | |
|---|---|
| 2023 | $-3.48 |
| 2022 | $-6.98 |
| 2021 | $-7.20 |
| 2020 | $-44.20 |
| 2019 | $-137.20 |
| 2018 | $-157.40 |
| 2017 | $-188.00 |
| 2016 | $-462.00 |
| 2015 | $-6,172.00 |
| 2014 | $-11,450.00 |
| 2013 | $-23,200.00 |
| 2012 | $-550.00 |
| 2011 | $-900.00 |
| 2010 | $-550.00 |
| 2009 | $-1,550.00 |
| Predictive Oncology Quarterly EPS | |
|---|---|
| 2023-12-31 | $-0.86 |
| 2023-09-30 | $-0.78 |
| 2023-06-30 | $-0.98 |
| 2023-03-31 | $-0.86 |
| 2022-12-31 | $-2.03 |
| 2022-09-30 | $-1.04 |
| 2022-06-30 | $-2.89 |
| 2022-03-31 | $-1.02 |
| 2021-12-31 | $-2.40 |
| 2021-09-30 | $-1.60 |
| 2021-06-30 | $-1.00 |
| 2021-03-31 | $-2.20 |
| 2020-12-31 | $-9.20 |
| 2020-09-30 | $-9.20 |
| 2020-06-30 | $-7.20 |
| 2020-03-31 | $-18.60 |
| 2019-12-31 | $-74.00 |
| 2019-09-30 | $-26.20 |
| 2019-06-30 | $4.80 |
| 2019-03-31 | $-41.80 |
| 2018-12-31 | $-49.60 |
| 2018-09-30 | $-37.80 |
| 2018-06-30 | $-40.00 |
| 2018-03-31 | $-30.00 |
| 2017-12-31 | $-32.00 |
| 2017-09-30 | $-32.00 |
| 2017-06-30 | $-82.00 |
| 2017-03-31 | $-42.00 |
| 2016-12-31 | $394.00 |
| 2016-09-30 | $-64.00 |
| 2016-06-30 | $-190.00 |
| 2016-03-31 | $-602.00 |
| 2015-12-31 | $-2,604.00 |
| 2015-09-30 | $-1,418.00 |
| 2015-06-30 | $-1,800.00 |
| 2015-03-31 | $-350.00 |
| 2014-12-31 | $-3,950.00 |
| 2014-09-30 | $-1,850.00 |
| 2014-06-30 | $-2,900.00 |
| 2014-03-31 | $-2,750.00 |
| 2013-12-31 | $-12,150.00 |
| 2013-09-30 | $-10,900.00 |
| 2013-06-30 | $-50.00 |
| 2013-03-31 | $-100.00 |
| 2012-12-31 | $-50.00 |
| 2012-09-30 | $-200.00 |
| 2012-06-30 | $-200.00 |
| 2012-03-31 | $-100.00 |
| 2011-12-31 | $-550.00 |
| 2011-09-30 | $-100.00 |
| 2011-06-30 | $-100.00 |
| 2011-03-31 | $-150.00 |
| 2010-12-31 | $-200.00 |
| 2010-09-30 | $-50.00 |
| 2010-06-30 | $0.00 |
| 2010-03-31 | $-300.00 |
| 2009-12-31 | $-150.00 |
| 2009-09-30 | $-400.00 |
| 2009-06-30 | $-400.00 |
| 2009-03-31 | $-600.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.007B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.221B | 21.82 |
| Inspire Medical Systems (INSP) | United States | $6.999B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.463B | 0.00 |
| Axonics (AXNX) | United States | $3.394B | 0.00 |
| 10x Genomics (TXG) | United States | $3.206B | 0.00 |
| Enovis (ENOV) | United States | $3.022B | 22.96 |
| Azenta (AZTA) | United States | $2.872B | 234.09 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.869B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.629B | 0.00 |
| Privia Health (PRVA) | United States | $2.135B | 94.68 |
| Schrodinger (SDGR) | United States | $1.688B | 0.00 |
| Omnicell (OMCL) | United States | $1.246B | 30.48 |
| Phreesia (PHR) | United States | $1.154B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.793B | 0.00 |
| Standard BioTools (LAB) | United States | $0.685B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
| Talkspace (TALK) | United States | $0.520B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.332B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.328B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.323B | 0.00 |
| Pulmonx (LUNG) | United States | $0.281B | 0.00 |
| American Well (AMWL) | United States | $0.156B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.152B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.147B | 0.00 |
| Augmedix (AUGX) | United States | $0.136B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.131B | 0.00 |
| Outset Medical (OM) | United States | $0.123B | 0.00 |
| TruBridge (TBRG) | United States | $0.115B | 4.91 |
| 111 (YI) | China | $0.084B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.077B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.045B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
| Movano (MOVE) | United States | $0.027B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |